These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26657735)

  • 21. Severe nasal presentation of antiphospholipid syndrome.
    Kim JE; Amin SH; Fong D; Gupta SK
    Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):298-301. PubMed ID: 21422317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
    Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
    J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.
    Yip J; Aghdassi E; Su J; Lou W; Reich H; Bargman J; Scholey J; Gladman DD; Urowitz MB; Fortin PR
    J Rheumatol; 2010 Aug; 37(8):1667-72. PubMed ID: 20516026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depressive symptoms and associated factors in systemic lupus erythematosus.
    Karol DE; Criscione-Schreiber LG; Lin M; Clowse ME
    Psychosomatics; 2013; 54(5):443-50. PubMed ID: 23274009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiovascular risk profile in systemic lupus erythematosus: a cross-sectional study of 879 patients].
    He CS; Shi W; Ye ZM; Liang XL; Zhang B; Liu SX
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1910-3. PubMed ID: 22126778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA; van Vollenhoven RF; Buyon J; Levy RA; Navarra SV; Cervera R; Zhong ZJ; Freimuth WW;
    Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 enhances the ability of SLE Responder Index to identify responders in clinical trials.
    Touma Z; Gladman DD; Ibañez D; Taghavi-Zadeh S; Urowitz MB
    J Rheumatol; 2011 Nov; 38(11):2395-9. PubMed ID: 21885488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The feet in systemic lupus erythematosus; are we underestimating their involvement and functional impact?
    Morales-Lozano R; Martínez-Barrio J; González-Fernández ML; López-Longo FJ; Ovalles-Bonilla JG; Valor L; Janta I; Nieto JC; Hernández-Flórez D; González CM; Monteagudo I; Garrido J; Carreño L; Naredo E
    Clin Exp Rheumatol; 2016; 34(4):609-17. PubMed ID: 27385118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of early cardiac dysfunction in patients with systemic lupus erythematosus with or without anticardiolipin antibodies.
    Barutcu A; Aksu F; Ozcelik F; Barutcu CA; Umit GE; Pamuk ON; Altun A
    Lupus; 2015 Sep; 24(10):1019-28. PubMed ID: 25697770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic lupus erythematosus patients in the low-latitude plateau of China: altitudinal influences.
    Qian G; Ran X; Zhou CX; Deng DQ; Zhang PL; Guo Y; Luo JH; Zhou XH; Xie H; Cai M
    Lupus; 2014 Dec; 23(14):1537-45. PubMed ID: 25059490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurately describing changes in disease activity in Systemic Lupus Erythematosus.
    Gladman DD; Urowitz MB; Kagal A; Hallett D
    J Rheumatol; 2000 Feb; 27(2):377-9. PubMed ID: 10685800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic lupus erythematosus disease activity index 2000.
    Gladman DD; Ibañez D; Urowitz MB
    J Rheumatol; 2002 Feb; 29(2):288-91. PubMed ID: 11838846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC; Manzi S; Kao AH; Navratil JS; Ruffing MJ; Ahearn JM
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric systemic lupus erythematosus: association with global disease activity.
    Morrison E; Carpentier S; Shaw E; Doucette S; Hanly JG
    Lupus; 2014 Apr; 23(4):370-7. PubMed ID: 24457602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragmented QRS complex in patients with systemic lupus erythematosus at the time of diagnosis and its relationship with disease activity.
    Hosonuma M; Yajima N; Takahashi R; Yanai R; Matsuyama TA; Toyosaki E; Saito J; Kusano K; Morita H
    PLoS One; 2020; 15(1):e0227022. PubMed ID: 31895922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Letter: Nasal-septum perforation in systemic lupus erythematosus.
    N Engl J Med; 1974 Jul; 291(1):51. PubMed ID: 4832409
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.